Technical Analysis for CTRV - ContraVir Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade F 0.2352 -8.30% -0.02
CTRV closed down 8.3 percent on Friday, March 22, 2019, on 76 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CTRV trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Down 4 Days in a Row Weakness 0.00%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup -8.30%
Mar 21 Narrow Range Bar Range Contraction -8.30%
Mar 21 NR7 Range Contraction -8.30%
Mar 21 NR7-2 Range Contraction -8.30%
Mar 21 Inside Day Range Contraction -8.30%

Older signals for CTRV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies. Its lead candidate, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus. The company has completed Phase I trials of FV-100 in volunteers, as well as a Phase IIa clinical trial in shingles patients. It also plans to conduct a trial in patients with shingles to further explore FV-100's potential to treat the long-lasting nerve pain typically associated with shingles. The company was founded in 2013 and is headquartered in Edison, New Jersey. ContraVir Pharmaceuticals, Inc. is a former subsidiary of Synergy Pharmaceuticals, Inc.
Biopharmaceutical Infectious Diseases Infection Antiviral Drug Viral Diseases Antivirals Herpes Simplex Virology Shingles Varicella Zoster Virus
Is CTRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.6
52 Week Low 0.213
Average Volume 259,513
200-Day Moving Average 0.6257
50-Day Moving Average 0.2759
20-Day Moving Average 0.2484
10-Day Moving Average 0.2595
Average True Range 0.037
ADX 31.01
+DI 26.4837
-DI 18.5966
Chandelier Exit (Long, 3 ATRs ) 0.249
Chandelier Exit (Short, 3 ATRs ) 0.326
Upper Bollinger Band 0.2867
Lower Bollinger Band 0.2101
Percent B (%b) 0.33
BandWidth 30.837359
MACD Line -0.0027
MACD Signal Line -0.0058
MACD Histogram 0.0031
Fundamentals Value
Market Cap 18.35 Million
Num Shares 78 Million
EPS -0.30
Price-to-Earnings (P/E) Ratio -0.78
Price-to-Sales 0.00
Price-to-Book 5.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.30
Resistance 3 (R3) 0.30 0.28 0.29
Resistance 2 (R2) 0.28 0.26 0.28 0.28
Resistance 1 (R1) 0.26 0.25 0.25 0.26 0.28
Pivot Point 0.24 0.24 0.23 0.24 0.24
Support 1 (S1) 0.22 0.22 0.21 0.22 0.19
Support 2 (S2) 0.20 0.21 0.20 0.19
Support 3 (S3) 0.18 0.20 0.19
Support 4 (S4) 0.18